Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerance of Regadenoson in Subjects With Asthma or COPD
NCT00862641Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD), sponsored by Astellas Pharma. Started Apr 2009; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00862641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862641.